CGEM: Cullinan Therapeutics, Inc. Stock

by  •  • Comments Off on CGEM: Cullinan Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 1,210.14
Enterprise Value ($M) 1,111.90
Book Value ($M) 453.89
Book Value / Share 10.54
Price / Book 2.67
NCAV ($M) 449.90
NCAV / Share 10.45
Price / NCAV 2.69

Profitability (mra)
Return on Invested Capital (ROIC) -0.33
Return on Assets (ROA) -0.30
Return on Equity (ROE) -0.32

Liquidity (mrq)
Quick Ratio 17.07
Current Ratio 17.07

Balance Sheet (mrq) ($M)
Current Assets 480.19
Assets 484.18
Liabilities 30.29
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -190.65
Net Income -153.16

Cash Flow Statement (mra) ($M)
Cash From Operations -134.28
Cash from Investing 35.81
Cash from Financing 40.75

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
9 days ago 13G Flynn James E 5.71
02-14 13G Blue Owl Capital Holdings LP 7.99
02-14 13G/A Biotechnology Value Fund L P 9.99 -41.49
02-14 13G/A Jovan-Embiricos Morana 5.09 -42.46
02-13 13G/A Vanguard Group Inc 4.14 -37.03
02-06 13G Franklin Resources Inc 7.70
01-29 13G BlackRock Inc. 5.80 20.90

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-14 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-11 10-Q Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-02 133,683 619,577 21.58
2024-05-01 285,016 1,442,282 19.76
2024-04-30 323,899 378,360 85.61
2024-04-29 524,928 592,318 88.62

(click for more detail)

Similar Companies
CABA – Cabaletta Bio, Inc. CCCC – C4 Therapeutics, Inc.
CGC – Canopy Growth Corporation CGON – CG Oncology, Inc.
COGT – Cogent Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io